英国1989-2012年口服抗生素使用与结直肠癌风险:匹配病例对照研究
该匹配病例对照研究基于英国临床实践研究数据链(1989-2012年),纳入28 980例结直肠癌病例和137 077例对照,评估口服抗生素暴露与结直肠癌风险的关联。结果显示,口服抗生素使用与结肠癌风险增加呈剂量依赖关系,而与直肠癌风险呈负相关,效应因肿瘤解剖位置和抗生素种类而异。
要点
- 口服抗生素使用增加结肠癌风险,呈剂量依赖(ptrend<0.001),近端结肠最显著。
- 抗生素使用与直肠癌风险呈负相关(ptrend=0.003),暴露>60天者aOR=0.85。
- 青霉素类(氨苄西林/阿莫西林)增加结肠癌风险(aOR=1.09),四环素类降低直肠癌风险(aOR=0.90)。
核心结论
- 口服抗生素使用与结肠癌风险增加相关,但与直肠癌风险降低相关。
- 抗生素与结直肠癌风险的关联因肿瘤解剖位置和抗生素种类而异,提示下消化道不同部位肠道菌群和致癌机制存在差异。
研究设计与样本
- 匹配病例对照研究,使用英国临床实践研究数据链(1989-2012年)。
- 纳入28 980例结直肠癌病例和137 077例对照(每例病例最多匹配5例对照)。
主要发现
- 口服抗生素使用与结肠癌风险增加呈剂量依赖关系(ptrend<0.001),最小使用后即可观察到风险,近端结肠和具抗厌氧菌活性的抗生素风险最大。
- 抗生素使用与直肠癌风险呈负相关(ptrend=0.003),抗生素暴露>60天者与未暴露相比aOR=0.85(95%CI 0.79-0.93)。
- 青霉素类,尤其是氨苄西林/阿莫西林,增加结肠癌风险(aOR=1.09,95%CI 1.05-1.13);四环素类降低直肠癌风险(aOR=0.90,95%CI 0.84-0.97)。
- 抗生素使用与肿瘤位置存在显著交互作用(结肠vs直肠,pinteraction<0.001;近端结肠vs远端结肠,pinteraction=0.019)。
- 诊断前>10年的抗生素暴露与结直肠癌风险相关(aOR=1.17,95%CI 1.06-1.31)。
临床怎么用
- 对于有口服抗生素使用史的患者,尤其是长期或使用青霉素类者,应关注结肠癌风险,必要时结合肿瘤位置评估。
- 四环素类使用与直肠癌风险降低相关,但需谨慎解读,不作为预防推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Microbiome dysbiosis predisposes to colorectal cancer (CRC), but a population-based study of oral antibiotic exposure and risk patterns is lacking. OBJECTIVE: To assess the association between oral antibiotic use and CRC risk. DESIGN: A matched case-control study (incident CRC cases and up to five matched controls) was performed using the Clinical Practice Research Datalink from 1989 to 2012. RESULTS: 28 980 CRC cases and 137 077 controls were identified. Oral antibiotic use was associated with CRC risk, but effects differed by anatomical location. Antibiotic use increased the risk of colon cancer in a dose-dependent fashion (ptrend <0.001). The risk was observed after minimal use, and was greatest in the proximal colon and with antibiotics with anti-anaerobic activity. In contrast, an inverse association was detected between antibiotic use and rectal cancers (ptrend=0.003), particularly with length of antibiotic exposure >60 days (adjusted OR (aOR), 0.85, 95% CI 0.79 to 0.93) as compared with no antibiotic exposure. Penicillins, particularly ampicillin/amoxicillin increased the risk of colon cancer (aOR=1.09 (1.05 to 1.13)), whereas tetracyclines reduced the risk of rectal cancer (aOR=0.90 (0.84 to 0.97)). Significant interactions were detected between antibiotic use and tumour location (colon vs rectum, pinteraction<0.001; proximal colon versus distal colon, pinteraction=0.019). The antibiotic-cancer association was found for antibiotic exposure occurring >10 years before diagnosis (aOR=1.17 (1.06 to 1.31)). CONCLUSION: Oral antibiotic use is associated with an increased risk of colon cancer but a reduced risk of rectal cancer. This effect heterogeneity may suggest differences in gut microbiota and carcinogenesis mechanisms along the lower intestinal tract.
引用
- Zhang J, Haines C, Watson AJM, et al. Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study. Gut. 2019. PMID: 31427405. doi:10.1136/gutjnl-2019-318593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。